Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Inventory (2019 - 2025)

Bioadaptives' Inventory history spans 7 years, with the latest figure at $44228.0 for Q3 2025.

  • For Q3 2025, Inventory changed N/A year-over-year to $44228.0; the TTM value through Sep 2025 reached $44228.0, changed N/A, while the annual FY2024 figure was $19115.0, 25.09% up from the prior year.
  • Inventory for Q3 2025 was $44228.0 at Bioadaptives, up from $39574.0 in the prior quarter.
  • Across five years, Inventory topped out at $44228.0 in Q3 2025 and bottomed at $3572.0 in Q1 2022.
  • The 5-year median for Inventory is $10124.0 (2021), against an average of $15014.8.
  • The largest annual shift saw Inventory crashed 70.93% in 2022 before it skyrocketed 559.57% in 2025.
  • A 5-year view of Inventory shows it stood at $4750.0 in 2021, then soared by 86.88% to $8877.0 in 2022, then surged by 72.14% to $15281.0 in 2023, then rose by 25.09% to $19115.0 in 2024, then surged by 131.38% to $44228.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Inventory are $44228.0 (Q3 2025), $39574.0 (Q2 2025), and $40584.0 (Q1 2025).